Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.059 CHF | -6.35% | -21.96% | +43.90% |
05-01 | SIX Swiss Exchange Approves Delay in Spexis' FY23 Annual Report Publication | MT |
04-17 | Santhera Pharmaceuticals Terminates Cystic Fibrosis Drug License Deal with Spexis | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+43.90% | 4.37M | |
-2.00% | 90.02B | |
-1.18% | 39.15B | |
-15.83% | 31.71B | |
+62.86% | 26.47B | |
-21.68% | 14.34B | |
-8.73% | 12.89B | |
-15.05% | 11.18B | |
-45.69% | 10.97B | |
+4.94% | 8.94B |
- Stock Market
- Equities
- POLN Stock
- News Spexis AG
- Polyphor Appoints Debra Barker as Chief Medical and Development Officer, Effective May 01, 2017